Evaluation of 1‐arylpiperazine derivative of hydroxybenzamides as 5‐HT1A and 5‐HT7 serotonin receptor ligands: An experimental and molecular modeling approach

The synthesis and evaluation as 5‐HT_1A and 5‐HT₇ serotonin receptor ligands of the two sets of O‐substituted hydroxybenzamides, structurally related to 2‐{3‐[4‐(2‐methoxyphenyl)piperazin‐1‐yl]propoxy}benzamide ( 1 ), (K_i 5‐HT_1A = 21 nM, 5‐HT₇ = 234 nM) are reported. To affect the affinity for 5‐HT_1A and 5‐HT₇ receptors, an amide moiety ( 2 , 3 , 4 , 5 , 6 ) and a hydrocarbon chain length ( 7 , 8 , 9 , 10 ) were modified. The serotonergic activity of compounds 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 was generally higher in the case of 5‐HT_1A receptors compared with 5‐HT₇ ones; the most active 5‐HT_1A ligands being meta‐isomer 2 (K_i = 7 nM) and both analogs of 1 with the longest spacer, i.e., penta‐ and hexa‐methylene derivatives 9 and 10 (K_i = 4 and 3 nM, respectively). The observed biological properties of compounds 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 were elucidated using molecular modeling procedures. J. Heterocyclic Chem., (2010).     

Multidimensional De Novo Design Reveals 5‐HT2B Receptor‐Selective Ligands

We report a multi‐objective de novo design study driven by synthetic tractability and aimed at the prioritization of computer‐generated 5‐HT_2B receptor ligands with accurately predicted target‐binding affinities. Relying on quantitative bioactivity models we designed and synthesized structurally novel, selective, nanomolar, and ligand‐efficient 5‐HT_2B modulators with sustained cell‐based effects. Our results suggest that seamless amalgamation of computational activity prediction and molecular design with microfluidics‐assisted synthesis enables the swift generation of small molecules with the desired polypharmacology.     

Mechanistic Studies on the Stereoselectivity of the Serotonin 5‐HT1A Receptor

G‐protein‐coupled receptors (GPCRs) are involved in a wide range of physiological processes, and they have attracted considerable attention as important targets for developing new medicines. A central and largely unresolved question in drug discovery, which is especially relevant to GPCRs, concerns ligand selectivity: Why do certain molecules act as activators (agonists) whereas others, with nearly identical structures, act as blockers (antagonists) of GPCRs? To address this question, we employed all‐atom, long‐timescale molecular dynamics simulations to investigate how two diastereomers (epimers) of dihydrofuroaporphine bind to the serotonin 5‐HT_1A receptor and exert opposite effects. By using molecular interaction fingerprints, we discovered that the agonist could mobilize nearby amino acid residues to act as molecular switches for the formation of a continuous water channel. In contrast, the antagonist epimer remained firmly stabilized in the binding pocket.     

Synthesis and biological properties of 1,8‐naphthalimidebutylamines. Serotonin 5‐HT1A and 5‐HT7 binding data and pass‐assisted search

Syntheses of the N‐substituted butyl derivatives of 1,8‐naphthalimide ( 1‐8 ), containing various arylpiperazines, tetrahydroisoquinoline and methylhomopiperazine moieties attached at 4‐position of the butyl chain have been described. Biological activities were evaluated in vitro for their ability to bind to serotonin 5‐HT_1A and 5‐HT₇ receptors. Due to the structural similarity of derivatives 1‐8 to psychotropic agents, the pharmacological properties of target compounds were predicted using PASS program.     

catena‐Poly[[μ‐hexa­nedioato‐1κO1:2κO6‐bis­[aqua­(5‐carboxy­penta­noato‐κO)copper(II)]]‐di‐μ‐4,4′‐bipyridine‐1κN:1′κN′;2κN:2′κN′]

In the title compound, [Cu₂(C₆H₈O₄)(C₆H₉O₄)₂(C₁₀H₈N₂)₂(H₂O)₂]_n, the square‐pyramidally coordinated Cu atoms are bridged by both 4,4‐bipyridine and adipate ligands into ladder‐­like chains, with exo‐orientated 5‐carboxypentan­oate ligands pendant from both side rails. Half of the adipate ligand is related to the other half by inversion symmetry. Inter­chain O—H⋯O hydrogen bonds from the aqua ligands to the carbonyl O atoms of the 5‐carboxy­penta­noate ligands are responsible for the formation of two‐dimensional grid‐like (4,4)‐networks, which complete a twofold inter­penetration.     

Poly[[(μ2‐4,4′‐bipyridine)(μ3‐5‐isonicotinamidoisophthalato)cobalt(II)] trihydrate]

In the title compound, {[Co(C₁₄H₈N₂O₅)(C₁₀H₈N₂)]·3H₂O}_n, the Co^II cation is five‐coordinated with a slightly distorted trigonal–bipyramidal geometry, and the 5‐isonicotinamidoisophthalate ligands link Co^II atoms into a layered structure. These two‐dimensional arrays are further pillared by rod‐like 4,4′‐bipyridine ligands to give a three‐dimensional framework with pcu (primitive cubic) topology. The magnetic and adsorption properties of the title compound are also discussed.     

[5‐Benzyl‐3‐phenyl‐2‐(2‐pyridyl‐κN)thiazolidin‐4‐one‐κS]dichloropalladium(II)

The palladium(II) centre in the title compound, [PdCl₂(C₂₁H₁₈N₂OS)], is coordinated to the pyridyl N atom and to the thia­zolidinone S atom of the 5‐benzyl‐3‐phenyl‐2‐(2‐pyridyl)­thia­zolidin‐4‐one ligand, resulting in a five‐membered chelate ring. Two cis‐chloro ligands complete the square‐planar coordination environment of the metal. Although the geometry at the Pd centre is essentially planar, the N—Pd—S bite angle of 85.20 (8)° causes deviations in the cis angles from the ideal value of 90°. Opposite enantiomers form one‐dimensional chains in the cell via a short S?O intermolecular interaction.     

High-affinity interactions of ligands at recombinant Guinea pig 5HT7 receptors

The serotonin 5HT₇ receptor has been implicated in numerous physiological and pathological processes from circadian rhythms [1] to depression and schizophrenia. Clonal cell lines heterologously expressing recombinant receptors offer good models for understanding drug-receptor interactions and development of quantitative structure-activity relationships (QSAR). Comparative Molecular Field Analysis (CoMFA) is an important modern QSAR procedure that relates the steric and electrostatic fields of a set of aligned compounds to affinity. Here, we utilized CoMFA to predict affinity for a number of high-affinity ligands at the recombinant guinea pig 5HT₇ receptor. Using R-lisuride as the template, a final CoMFA model was derived using procedures similar to those of our recent papers [2, 3, 4] The final cross-validated model accounted for >85% of the variance in the compound affinity data, while the final non-cross validated model accounted for >99% of the variance. Model evaluation was done using cross-validation methods with groups of 5 ligands. Twenty cross-validation runs yielded an average predictive r²(q²) of 0.779 ± 0.015 (range: 0.669–0.867). Furthermore, 3D-chemical database search queries derived from the model yielded hit lists of promising agents with high structural similarity to the template. Together, these results suggest a possible basis for high-affinity drug action at 5HT₇ receptors.     

Synthesis and Reactivity of 5‐Bromopenta‐2,4‐diynenitrile (BrC5N): an Access to π‐Conjugated Scaffolds

The synthesis of 5‐bromopenta‐2,4‐diynenitrile (BrC₅N) in three steps from commercially available compounds is reported. Reacting 5‐bromopenta‐2,4‐diynenitrile with secondary amines led to the formation of stable butadiynamines or enynenitriles, depending on the nature of the amine reactant. The reaction of 5‐bromopenta‐2,4‐diynenitrile with simple terminal alkynes in the presence of secondary amines, copper, and palladium catalysts, provided a straightforward access to original polyfunctional carbon‐rich scaffolds. In this work, different alkynes and secondary amines were tested, which allowed for the preparation of a family of substituted dienes. Given the high synthetic potential of 5‐bromopenta‐2,4‐diynenitrile, we also prepared iodinated counterparts of this compound, that is, 5‐iodopenta‐2,4‐diynenitrile and its lower homologue 3‐iodopropiolonitrile. The UV‐visible spectrum of some relevant compounds was also recorded.     

2,2‐Dimethyl‐5‐nitroso‐1,3‐dioxan‐5‐yl benzoate, 2,2‐dimethyl‐5‐nitroso‐1,3‐dioxan‐5‐yl 4‐chlorobenzoate and 5‐nitroso‐1,3‐dioxan‐5‐yl 4‐chlorobenzoate

The crystal structures of 2,2‐dimethyl‐5‐nitroso‐1,3‐dioxan‐5‐yl benzoate, C₁₃H₁₅NO₅, (I), 2,2‐dimethyl‐5‐nitroso‐1,3‐dioxan‐5‐yl 4‐chlorobenzoate, C₁₃H₁₄ClNO₅, (II), and 5‐nitroso‐1,3‐dioxan‐5‐yl 4‐chlorobenzoate, C₁₁H₁₁NO₅, (III), have been determined in order to gain insight into the conformational preference of α‐benzoyloxynitroso. Unfavourable 1,3‐diaxial interactions force (I) and (II) to crystallize in the 2,5 twist‐boat conformation, whereas compound (III), lacking this destabilizing interaction, crystallizes in the chair conformation.     

Synthesis of optically active af‐(1‐Ethyl‐3‐methylhexahydro‐1,3‐diazin‐5‐yl)‐ and N‐(1‐Ethyl‐5‐methyloctahydro‐1,5‐diazocin‐3‐yl)pyridine‐3‐carboxamides

As part of the structure‐activity relationship of the dopamine D₂ and serotonin 5‐HT₃ receptors antagonist 1, which is a clinical candidate with a broad antiemetic activity, the synthesis and dopamine D₂ and serotonin 5‐HT₃ receptors binding affinity of (R)‐5‐bromo‐N‐(1‐ethyl‐3‐methylhexahydro‐1,3‐diazin‐5‐yl)‐ and (R)‐5‐bromo‐N‐(1‐ethyl‐5‐methyloctahydro‐1,5‐diazocin‐3‐yl)‐2‐methoxy‐6‐methylaminopyridine‐3‐carboxam‐ides ( 2 and 3 ) are described. Treatment of 1‐ethyl‐2‐(p‐toluenesulfonyl)amino‐3‐methylaminopropane dihy‐drochloride ( 4a ) with paraformaldehyde and successive deprotection gave the 5‐aminohexahydro‐1,3‐diazine 6 in excellent yield. 3‐Amino‐1‐ethyl‐5‐methyloctahydro‐1,5‐diazocine ( 15 ) was prepared from 2‐(benzyloxycarbonyl)amino‐3‐[[N‐(tert‐butoxycarbonyl)‐N‐methyl]amino]‐1‐ethylaminopropane ( 9 ) through the intramolecular amidation of (R)‐3‐[N‐[(2‐benzyloxycarbonylamino‐3‐methylamino)propyl]‐N‐ethyl]aminopropionic acid trifluoroacetate ( 12 ), followed by lithium aluminum hydride reduction of the resulting 6‐oxo‐1‐ethyl‐5‐methyloctahydrodiazocine ( 13 ) in 41% yield. Reaction of the amines 6 and 15 with 5‐bromo‐2‐methoxy‐6‐methylaminopyridine‐3‐carboxylic acid furnished the desired 2 and 3 , which showed much less potent affinity for dopamine D₂ receptors than 1 .     

A three‐dimensional polymeric potassium complex of 5‐sulfonobenzene‐1,2,4‐tricarboxylic acid: poly[μ‐aqua‐aqua‐μ9‐(2,4‐dicarboxy‐5‐sulfonatobenzoato)‐dipotassium(I)]

The asymmetric unit in the structure of the title compound, [K₂(C₉H₄O₉S)(H₂O)₂]_n, consists of two eight‐coordinated K^I cations, one 2,4‐dicarboxy‐5‐sulfonatobenzoate dianion (H₂SBTC²⁻), one bridging water molecule and one terminal coordinated water molecule. One K^I cation is coordinated by three carboxylate O atoms and three sulfonate O atoms from four H₂SBTC²⁻ ligands and by two bridging water molecules. The second K^I cation is coordinated by four sulfonate O atoms and three carboxylate O atoms from five H₂SBTC²⁻ ligands and by one terminal coordinated water molecule. The K^I cations are linked by sulfonate groups to give a one‐dimensional inorganic chain with cage‐like K₄(SO₃)₂ repeat units. These one‐dimensional chains are bridged by one of the carboxylic acid groups of the H₂SBTC²⁻ ligand to form a two‐dimensional layer, and these layers are further linked by the remaining carboxylate groups and the benzene rings of the H₂SBTC²⁻ ligands to generate a three‐dimensional framework. The compound displays a photoluminescent emission at 460 nm upon excitation at 358 nm. In addition, the thermal stability of the title compound has been studied.     

η5‐(3)‐1‐Methyl‐1,2‐dicarbollyl‐η5‐2′,5′‐dimethylpyrrolylcobalt(III)

In the title compound, (η⁵‐2,5‐di­methyl­pyrrolyl)[(7,8,9,10,11‐η)‐7‐methyl‐7,8‐dicarba‐nido‐undecaborato]­cobalt(III), [3‐Co{η⁵‐[2,5‐(CH₃)₂‐NC₄H₂]}‐1‐CH₃‐1,2‐C₂B₉H₁₀] or [Co(C₃H₁₃B₉)(C₆H₈N)], the Co^III atom is sandwiched between the pentagonal faces of the pyrrolyl and dicarbollide ligands, resulting in a neutral mol­ecule. The C—C distance in the dicarbollide cage is 1.649 (3) Å.     

Ethyl[tris(3‐tert‐butyl‐5‐methylpyrazol‐1‐yl)hydridoborato]zinc(II)

The X‐ray crystal structure of the title compound, [Zn(C₂H₅)(C₂₄H₄₀BN₆)], or Tp^tBu,MeZnEt [Tp^tBu,Me is tris(3‐tert‐butyl‐5‐methylpyrazolyl)hydridoborate], reveals a distorted tetrahedral geometry around the Zn atom. The Zn center is coordinated by three N atoms of the borate ligand and by one C atom of the ethyl group. The present structure and other tetrahedral Tp zinc alkyl complexes are compared with similar Ttz ligands (Ttz is 1,2,4‐triazolylborate), but no major differences in the structures are noted, and it can be assumed that variation of the substitution pattern of Tp or Ttz ligands has little or no influence on the geometry of alkylzinc complexes. Refinement of the structure is complicated by a combination of metric pseudosymmetry and twinning. The metrics of the structure could also be represented in a double‐volume C‐centered orthorhombic unit cell, and the structure is twinned by one of the orthorhombic symmetry operators not present in the actual structure. The twinning lies on the borderline between pseudomerohedral and nonmerohedral. The data were refined as being nonmerohedrally twinned, pseudomerohedrally twinned and untwinned. None of the approaches yielded results that were unambiguously better than any of the others: the best fit between structural model and data was observed using the nonmerohedral approach which also yielded the best structure quality indicators, but the data set is less than 80% complete due to rejected data. The pseudomerohedral and the untwinned structures are complete, but relatively large residual electron densities that are not close to the metal center are found with values up to three times higher than in the nonmerohedral approach.     

(6‐Oxido‐2‐oxo‐1,2‐dihydropyrimidine‐5‐carboxylato‐κ2O5,O6)bis[2‐(2‐pyridyl)‐1H‐benzimidazole‐κ2N2,N3]manganese(II) monohydrate

In the title compound, [Mn(C₅H₂N₂O₄)(C₁₂H₉N₃)₂]·H₂O, the Mn^II centre is surrounded by three bidentate chelating ligands, namely, one 6‐oxido‐2‐oxo‐1,2‐dihydropyrimidine‐5‐carboxylate (or uracil‐5‐carboxylate, Huca²⁻) ligand [Mn—O = 2.136 (2) and 2.156 (3) Å] and two 2‐(2‐pyridyl)‐1H‐benzimidazole (Hpybim) ligands [Mn—N = 2.213 (3)–2.331 (3) Å], and it displays a severely distorted octahedral geometry, with cis angles ranging from 73.05 (10) to 105.77 (10)°. Intermolecular N—H...O hydrogen bonds both between the Hpybim and the Huca²⁻ ligands and between the Huca²⁻ ligands link the molecules into infinite chains. The lattice water molecule acts as a hydrogen‐bond donor to form double O...H—O—H...O hydrogen bonds with the Huca²⁻ O atoms, crosslinking the chains to afford an infinite two‐dimensional sheet; a third hydrogen bond (N—H...O) formed by the water molecule as a hydrogen‐bond acceptor and a Hpybim N atom further links these sheets to yield a three‐dimensional supramolecular framework. Possible partial π–π stacking interactions involving the Hpybim rings are also observed in the crystal structure.     

A rare `mesh of trees' (mot) net: poly[aquahemi[μ4‐1,6‐bis(1,2,4‐triazol‐1‐yl)hexane](μ2‐5‐nitroisophthalato)cadmium(II)]

In the title coordination compound, [Cd(C₈H₃NO₆)(C₅H₈N₃)_0.5(H₂O)]_n, each Cd^II atom is six‐coordinated in a distorted octahedral environment surrounded by three carboxylate O atoms from two different 5‐nitroisophthalate (5‐NIP²⁻) ligands, two N atoms from two distinct 1,6‐bis(1,2,4‐triazol‐1‐yl)hexane (bth) ligands and one water molecule. The Cd^II centres are bridged by the bth ligands, which lie across centres of inversion, to give a honeycomb‐like two‐dimensional layer structure; the layers are further connected by the bridging 5‐NIP²⁻ ligands with a κ²;κ¹‐μ₂ coordination mode to generate the final three‐dimensional structure. Topologically, taking the the Cd^II atoms and the bth ligands as different four‐connected nodes and the 5‐NIP²⁻ ligands as linkers, the three‐dimensional structure can be simplified to a rare `mesh of trees' (mot) net with the Schäfli symbol (6⁶)(6⁴.8²)₂.     

Poly[[[bis­(N,N′‐dimethyl­formamide)­zinc(II)]‐μ3‐5‐hydroxy­benzene‐1,3‐dicarboxyl­ato] toluene solvate]

The title compound, {[Zn(C₈H₄O₅)(C₃H₇NO)₂]·0.5C₇H₈}_n, is a one‐dimensional coordination polymer in which the Zn atoms are linked by bridging 5‐hydroxy­benzene‐1,3‐dicarboxyl­ate ligands. These polymeric chains form two‐dimensional sheets via interchain hydrogen bonds, and these sheets, in turn, are stacked tightly with solvent toluene mol­ecules in the inter­layer space. The N,N′‐dimethyl­formamide ligands, coordinated axially to the Zn atoms, form van der Waals contacts with ligands in neighboring sheets, and enclose the guest mol­ecules.     

Poly[aquaneodymium(III)‐μ5‐2‐oxido‐5‐sulfonatobenzoato]

The title compound, [Nd(C₇H₃O₆S)(H₂O)]_n or [Nd(SSA)(H₂O)]_n (H₃SSA is 5‐sulfosalicylic acid), was synthesized by the hydrothermal reaction of Nd₂O₃ with H₃SSA in water. The compound forms a three‐dimensional network in which the asymmetric unit contains one Nd^III atom, one SSA ligand and one coordinated water mol­ecule. The central Nd^III ion is eight‐coordinate, bonded to seven O atoms from five different SSA ligands [Nd—O = 2.405 (4)–2.612 (4) Å] and one aqua O atom [Nd—OW = 2.441 (4) Å].     

A fourfold interpenetrating diamondoid three‐dimensional coordination polymer: poly[[[μ2‐1,2‐bis(pyridin‐4‐yl)ethene‐κ2N:N′](μ2‐5‐hydroxyisophthalato‐κ2O1:O3)zinc(II)] 1,2‐bis(pyridin‐4‐yl)ethene hemisolvate]

In the title compound, {[Zn(C₈H₄O₅)(C₁₂H₁₀N₂)]·0.5C₁₂H₁₀N₂}_n or {[Zn(HO‐BDC)(bpe)]·0.5bpe}_n [HO‐H₂BDC is 5‐hydroxyisophthalic acid and bpe is 1,2‐bis(pyridin‐4‐yl)ethene], the asymmetric unit contains a Zn^II atom, one HO‐BDC ligand, one coordinated bpe ligand and half a noncoordinating bpe molecule with crystallographic inversion symmetry. Each Zn^II centre is four‐coordinated by two O atoms from two distinct HO‐BDC ligands and two N atoms from two different bpe ligands in a ZnO₂N₂ coordination environment. The three‐dimensional topology of the title compound corresponds to a fourfold interpenetrating diamondoid coordination polymer network, with the uncoordinated bpe ligands located in the cavities, hydrogen bonded to the main network via the hydroxy group of the HO‐H₂BDC ligand.     

Pentafluoro(aryl)‐λ6‐tellanes and Tetrafluoro(aryl)(trifluoromethyl)‐λ6‐tellanes: From SF5 to the TeF5 and TeF4CF3 Groups

The TeF₅ group is significantly underexplored as a highly fluorinated substituent on an organic framework, despite it being a larger congener of the acclaimed SF₅ group. In fact, only one aryl‐TeF₅ compound (phenyl‐TeF₅) has been reported to date, synthesized using XeF₂. Our recently developed mild TCICA/KF approach to oxidative fluorination provides an affordable and scalable alternative to XeF₂. Using this method, we report a scope of extensively characterized aryl‐TeF₅ compounds, along with the first SC‐XRD data on this compound class. The methodology was also extended to the synthesis and structural study of heretofore unknown aryl‐TeF₄CF₃ compounds. Additionally, preliminary reactivity studies unveiled some inconsistencies with previous literature regarding phenyl‐TeF₅. Although our studies conclude that the arene‐based TeF₅ (and TeF₄CF₃) group is not quite as robust as the SF₅ group, we find that the TeF₅ group is more stable than previously thought, thus opening a door to explore new applications of this motif.